Brief: Healthtech Inc Announces U.S. Appeals Court Final Ruling On Nicotinamide Riboside Intellectual Property Claim
09/01/2023 21:55
Jan 9 (Reuters) - Thorne Healthtech Inc THRN.O :
* U.S. APPEALS COURT ISSUES FINAL RULING THAT UPHOLDS THORNE
HEALTHTECH INC.'S PRIOR CHALLENGE OF NICOTINAMIDE RIBOSIDE
INTELLECTUAL PROPERTY CLAIM
Source text for Eikon: ID:nPn16v1nGa
Further company coverage: THRN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Thorne HealthTech
See all newsBrief: L Catterton And Thorne Healthtech, Inc. Announce Expiration Of Tender Offer
Brief: L Catterton And Thorne Healthtech Announce Expiration Of Tender Offer
Brief: Thorne Healthtech Received Notice Of Delisting From Nasdaq
Brief: Kirin Holdings To Sell All Of 29.1% Stake It Owns In Thorne Healthtech For About 23 Billion Yen - Nikkei
U.S. RESEARCH ROUNDUP- Celsius Holdings, RPT Realty, Thorne Healthtech